Evidence map›Paper›PMID 37526817›Full record

ArticleJournal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology2023

Characterization of Depression- and Anxiety-Like Behaviours in a Mouse Model of Relapsing-Remitting Multiple Sclerosis.

Diulle Spat Peres, Fernanda Tibolla Viero, Patrícia Rodrigues, Laura de Barros Bernardes, Náthaly Andriguetto Ruviaro da Silva, Igor Ramos Lima, Gabrielli Martins, Paulo Cesar Lock Silveira, Marcella de Amorim Ferreira, Ana Merian Silva and 2 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Depression and anxiety in multiple sclerosis. Review of a fatal combination.Journal of neural transmission (Vienna, Austria : 1996) · 2024
    Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Diulle Spat PeresGraduated Program in Pharmacology, Federal University of Santa Maria (UFSM), Avenida Roraima, 1000, building 21, room 5207, Santa Maria (RS), 97105-900, Brazil.
Fernanda Tibolla VieroGraduated Program in Pharmacology, Federal University of Santa Maria (UFSM), Avenida Roraima, 1000, building 21, room 5207, Santa Maria (RS), 97105-900, Brazil.
Patrícia RodriguesGraduated Program in Pharmacology, Federal University of Santa Maria (UFSM), Avenida Roraima, 1000, building 21, room 5207, Santa Maria (RS), 97105-900, Brazil.
Laura de Barros BernardesGraduated Program in Pharmacology, Federal University of Santa Maria (UFSM), Avenida Roraima, 1000, building 21, room 5207, Santa Maria (RS), 97105-900, Brazil.
Náthaly Andriguetto Ruviaro da SilvaGraduated Program in Biological Sciences: Toxicological Biochemistry, Federal University of Santa Maria (UFSM), Santa Maria (RS), 97105-900, Brazil.
Igor Ramos LimaGraduate Program in Health Science, University of the Extreme South of Santa Catarina (Unesc), Criciúma, 88806-000, Brazil.
Gabrielli MartinsGraduate Program in Health Science, University of the Extreme South of Santa Catarina (Unesc), Criciúma, 88806-000, Brazil.
Paulo Cesar Lock SilveiraGraduate Program in Health Science, University of the Extreme South of Santa Catarina (Unesc), Criciúma, 88806-000, Brazil.
Marcella de Amorim FerreiraGraduate Program in Pharmacology, Federal University of Santa Catarina (UFSC), Florianopólis, 88037-000, Brazil.
Ana Merian SilvaGraduate Program in Pharmacology, Federal University of Santa Catarina (UFSC), Florianopólis, 88037-000, Brazil.
Juliano FerreiraGraduate Program in Pharmacology, Federal University of Santa Catarina (UFSC), Florianopólis, 88037-000, Brazil.
Gabriela TrevisanGraduated Program in Pharmacology, Federal University of Santa Maria (UFSM), Avenida Roraima, 1000, building 21, room 5207, Santa Maria (RS), 97105-900, Brazil. gabrielatrevisansantos@gmail.com.
Universidade Federal de Santa Maria · BRUniversidade do Extremo Sul Catarinense · BRUniversidade Federal de Santa Catarina · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Relapsing-remitting multiple sclerosis (RRMS) is an autoimmune neurological disease and is the most common subtype of MS. In addition, it is associated with the development of depression and anxiety. To date, depressive- and anxiety-like behaviours were only studied using models of progressive MS, which causes severe motor alterations. Thus, we sought to standardise the depressive and anxiety-like behaviours in an RRMS model induced by experimental autoimmune encephalomyelitis (RR-EAE) in mice. The RR-EAE model was induced in C57BL/6 female mice using myelin oligodendrocyte glycoprotein (MOG35-55) antigen and Quillaja saponin (Quil A) as an adjuvant. The immunisation of RR-EAE did not induce locomotor alteration but caused relapsing-remitting induction of clinical scores in mice until 35 post-immunization (p.i.). Also, increased levels of tumour necrosis factor alpha (TNF-α), astrocyte marker (GFAP), and microglial markers (IBA-1) were detected in the prefrontal cortex at 35 p.i. of RR-EAE. In the open field test, RR-EAE mice showed decreased time spent at the centre and sniffing behaviour (at days 21 and 34 p.i.). Also, on day 35 p.i. the RR-EAE group spent less time in the open arms and had decreased open-arm entries compared to control mice in the elevated plus maze (EPM) test, confirming the anxiety-like behaviour. At day 36° p.i. in the tail suspension test, mice showed depression-like behaviour with decreased latency time and increased immobility time. Thus, the RR-EAE model mimics the neuroinflammatory and behavioural features of the RRMS, including depression- and anxiety-like symptoms.

Indexed as

Encephalomyelitis, Autoimmune, ExperimentalMultiple SclerosisMultiple Sclerosis, Relapsing-RemittingAnimalsAnxietyDepressionDisease Models, AnimalFemaleMiceMice, Inbred C57BLMyelin-Oligodendrocyte GlycoproteinMyelin-Oligodendrocyte GlycoproteinElevated plus maze testGFAPIBAMOG35 − 55Tail suspension testTNF-α

Identifiers

PMID37526817
OpenAlexW4385442171

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.